🔎 Trials Near Me

Hjem › Lymfom › North Carolina › Durham

Lymfom kliniske forsøg i Durham, NC

17 studier for Lymfom søger deltagere på steder i og omkring Durham (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

RekruttererFase 2
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi væk
Alder 18 til 99 · Alle køn · Opdateret 24. sep. 2026 · NCT04083495

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

RekruttererFase 2
  • Duke University, Durham
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RekruttererFase 1/2
  • Duke University Medical Center, Durham
12 Months – 21 Years · Alle køn · Opdateret 11. sep. 2026 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

RekruttererFase 1/2
  • UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi væk
Alder 12 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT04588922

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Rekrutterer
  • Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi væk
Alder 60 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT06296368

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RekruttererFase 1/2
  • University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi væk
Alder 13 til 90 · Alle køn · Opdateret 6. aug. 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RekruttererFase 3
  • Duke Cancer Institute, Durham
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

RekruttererFase 2
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

RekruttererFase 1
  • Duke University Medical Center, Durham
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT05131022

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Rekrutterer
  • North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mi væk
Alder 18 og opefter · Alle køn · Opdateret 1. jul. 2026 · NCT06860880

Registry of Older Patients With Cancer

RekruttererObservationsstudie
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi væk
Alder 65 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT01137825

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RekruttererFase 1/2
  • Duke University Medical Center, Duke Cancer Center, Durham
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Rekrutterer
  • Duke Cancer Institute, Durham
Alder 18 til 39 · Alle køn · Opdateret 28. jan. 2026 · NCT06371768

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

RekruttererFase 1
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi væk
Alder 18 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT04223765

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RekruttererObservationsstudie
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi væk
Alder 18 til 120 · Alle køn · Opdateret 27. okt. 2025 · NCT01137643

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

RekruttererFase 2
  • Durham VA Medical Center, Durham, NC, Durham
Alder 18 til 80 · Alle køn · Opdateret 14. okt. 2025 · NCT06520098

Lymfom forsøg i andre byer

Andre studier i Durham

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.